Related Experiment Video
Updated: Apr 29, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Endocrine Characteristics in Bardet Biedl Syndrome from a Large Single-Centre Paediatric Multidisciplinary Clinic
Rachel S Varughese1, Divya Pujari1, Elizabeth Hatton2
1Great Ormond Street Hospital for Children, London, UK.
Insights
Short stature and obesity are common in children with Bardet-Biedl syndrome (BBS), a rare genetic disorder. However, endocrine issues like hypogonadism and hypothyroidism are less frequent in pediatric cases compared to adults.
Area of Science:
- Endocrinology
- Genetics
- Pediatrics
Background:
- Bardet-Biedl syndrome (BBS) is a rare genetic ciliopathy with diverse clinical manifestations.
- Endocrine complications, including obesity, short stature, and hypogonadism, are known associations of BBS.
- The endocrine characteristics in pediatric BBS populations are not well-documented.
Purpose of the Study:
- To analyze the endocrine characteristics of pediatric patients with genetically confirmed Bardet-Biedl syndrome.
- To describe the prevalence of short stature, obesity, and other endocrine dysfunctions in this cohort.
Main Methods:
- Retrospective analysis of prospectively collected data from a multidisciplinary BBS service.
- Inclusion of 135 pediatric patients with genetically confirmed BBS.
- Extraction of endocrine function data, including height, BMI, and metabolic markers.
Main Results:
- Short stature was present in 21.1% and obesity in 77.6% of patients aged ≥15 years.
- Elevated triglycerides were observed in 55.5% of patients.
- Hypogonadism and hypothyroidism were less prevalent than expected, with no patients requiring hormonal intervention.
Conclusions:
- Short stature and obesity are significant endocrine features in pediatric Bardet-Biedl syndrome.
- Hypogonadism and hypothyroidism appear less common in pediatric BBS than in adult populations.
- Further longitudinal studies are needed to understand the natural history of endocrine conditions in BBS across age groups.
Objective:
Bardet-Biedl syndrome (BBS) is a rare genetic ciliopathy characterised by obesity, rod-cone dystrophy, polydactyly, hypogonadism, cognitive impairment and renal abnormalities. Additional endocrine associations include short stature and hypothyroidism. The endocrine characteristics in children are not well described.
Methods:
A retrospective analysis of prospectively collected data in paediatric patients with genetically confirmed BBS from a single multidisciplinary BBS service. Data related to endocrine function were extracted from the electronic patient record. Height was reported for patients ≥4 years old and ≥15 years old. Short stature was defined as a height Z-score (standard deviation score, SDS) <-2 or height >1.6 SDS below the mid-parental height.
Results:
135 patients were included: 69 (51%) were female, ranging from 1.2-19.4 years old. At ≥15 years, 21.1% (12/57) had short stature and 77.6% (45/58) had obesity. On average, BMI worsened over time. Triglycerides were raised in 55.5% (66/119). No patients demonstrated biochemical or clinical evidence of persistent primary or secondary hypogonadism, and none required pubertal induction or sex steroid replacement therapy. Primary hypothyroidism and subclinical hypothyroidism were identified in 1.7% (2/121) and 0.8% (1/121), respectively. Type 1 diabetes, Type 2 diabetes and impaired glucose tolerance were identified in 1.5% (2/135), 2.2% (3/135) and 1.5% (2/135), respectively.
Conclusions:
This is the largest analysis of endocrine characteristics in paediatric patients with BBS. Short stature and obesity are characteristic of paediatric BBS. However, hypogonadism, hypothyroidism, and insulin resistance are less prevalent compared with adult BBS populations. Longitudinal studies spanning paediatric and adult populations may further characterise the natural history of these endocrine conditions associated with BBS.
More Related Videos
Related Concept Videos
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Lysosomal Hydrolases
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pedigree Analysis
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Inborn Errors of Metabolism

